Is nebulized saline a placebo in COPD?

S. Y. Khan, B. R. ODriscoll (Salford, United Kingdom)

Source: Annual Congress 2001 - COPD
Session: COPD
Session type: Oral Presentation
Number: 1320
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Y. Khan, B. R. ODriscoll (Salford, United Kingdom). Is nebulized saline a placebo in COPD?. Eur Respir J 2001; 16: Suppl. 31, 1320

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of magnesium sulfate to normal saline as a vehicle for nebulized salbutamol in children with acute asthma; a clinical trial
Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives
Year: 2008

Nebulized saline treatment in patients with concomitant asthma and bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021


A comparison of nebulized levalbuterol, albuterol, and combined albuterol and ipratropium in patients with stable COPD: preliminary observations
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002

Comparison of different dosage nebulised budesonide in COPD exacerbation
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012


Efficacy of nebulized arformoterol, a long-acting β2-adrenergic bronchodilator, in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 215s
Year: 2006

Comparison of nebulized ipratropium bromide with salbutamol versus salbutamol alone in acute asthma exacerbation in children
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004

Efficacy of formoterol 12μg dry powder capsules in 6,155 asthmatic patients poorly controlled with salmeterol or on-demand salbutamol (EFORA study)
Source: Eur Respir J 2002; 20: Suppl. 38, 107s
Year: 2002

Efficacy and safety of nebulized glycopyrrolate (EP-101) for administration using high efficiency nebulizer in patients with COPD
Source: Annual Congress 2011 - Bronchodilators in asthma and COPD
Year: 2011

A comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a double-blind, efficacy and safety study in Chinese adults with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 213s
Year: 2006

A randomized clinical trial of magnesium sulfate as a vehicle for nebulized salbutamol in the treatment of moderate to severe asthma attacks
Source: Eur Respir J 2004; 24: Suppl. 48, 343s
Year: 2004

Population pharmacokinetics of nebulized arformoterol in subjects with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 427s
Year: 2006

Comparison of oral prednisolone and nebulized budesonide in the treatment of acute exacerbations of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 214s
Year: 2001

Do infants with bronchiolitis get any benefit with nebulized salbutamol?
Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy
Year: 2011


Nebulized formoterol improves airway function in COPD subjects receiving maintenance tiotropium
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008

Lung deposition of the extrafine dry powder fixed combination beclomethasone dipropionate plus formoterol fumarate via the NEXT DPI® in healthy subjects, asthmatic and COPD patients
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011

Budesonide/formoterol in a single inhaler once or twice daily provides better asthma control than inhaled fluticasone or budesonide alone in patients with moderate persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 387s
Year: 2002

Τhe administration of nebulised racemic epinephrine in asthma exacerbations
Source: Eur Respir J 2004; 24: Suppl. 48, 541s
Year: 2004

Dose-finding study for tiotropium and olodaterol when administered in combination via the Respimat® inhaler in patients with COPD
Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights
Year: 2012


Efficacy and safety of twice-daily aclidinium bromide compared with tiotropium and placebo in patients with moderate to severe COPD
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010


Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010